Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPT2 | P23786 | 3/20 | 0.62 |
| ▸ | CPT1A | P50416 | 3/20 | 0.62 |
| ▸ | CPT1B | Q92523 | 3/20 | 0.62 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14108616 | 0.88 | CPT2 (0.74) | CPT2CPT1ACPT1BEPHX1 | |
| SCHEMBL12304894 | 0.83 | CPT2 (0.66) | CPT2CPT1ACPT1BEPHX2EPHX1 | |
| SCHEMBL12304897 | 0.81 | CPT2 (0.60) | CPT2CPT1ACPT1BEPHX2EPHX1 | |
| Teglicar SCHEMBL13568151 | 0.78 | CPT2 (0.78) | CPT2CPT1ACPT1BEPHX1 | |
| SCHEMBL12304895 | 0.78 | CPT2 (0.78) | CPT2CPT1ACPT1BEPHX1 | |
| SCHEMBL12304907 | 0.78 | CPT2 (0.78) | CPT2CPT1ACPT1BEPHX1 | |
| Teglicar SCHEMBL3685373 | 0.77 | CPT2 (1.00) | CPT2CPT1ACPT1B | |
| Teglicar SCHEMBL3687135 | 0.77 | CPT2 (1.00) | CPT2CPT1ACPT1B | |
| Teglicar SCHEMBL4450575 | 0.77 | CPT2 (1.00) | CPT2CPT1ACPT1B | |
| SCHEMBL2912378 | 0.77 | CPT2 (1.00) | CPT2CPT1ACPT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080161395-A1 | Derivatives of Aminobutanoic Acid Inhibiting Cpt | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2008-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080161395-A1 | Derivatives of Aminobutanoic Acid Inhibiting Cpt | CPT1B, CPT1A, CPT2 | CPT2 3/4885CPT1A 2/4885CPT1B 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.